首页> 美国卫生研究院文献>Human Vaccines Immunotherapeutics >Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa

【2h】

Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa

机译：与许可的Infanrix hexa疫苗相比，在六价DTPa-HBV-IPV / Hib联合疫苗中使用2种研究性白喉，破伤风和流感嗜血杆菌b型抗原的初次和加强疫苗接种的免疫原性和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Human Vaccines Immunotherapeutics
作者
Timo Vesikari; Luis Rivera; Tiina Korhonen; Anitta Ahonen; Brigitte Cheuvart; Marjan Hezareh; Winnie Janssens; Narcisa Mesaros;
展开▼
作者单位

展开▼
年(卷),期 2018(13),7
年度 2018
页码 1505–1515
总页数 11
原文格式 PDF
正文语种
中图分类免疫学;
关键词

相似文献

外文文献
中文文献
专利

1. Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa [J] . Vesikari Timo, Rivera Luis, Korhonen Tiina, Human vaccines & immunotherapeutics. . 2017,第7期

机译：与六价DTPA-HBV-IPV / HIB组合疫苗中的二色菌，破伤风和嗜血杆菌流感型B抗原的2种研究制剂的免疫原性和安全性，与持久的infanrix Hexa相比
2. Safety and immunogenicity of a diphtheria, tetanus, acellular pertussis and Haemophilus influenzae Type b combination vaccine compared with separate administration of licensed equivalent vaccines in Chinese infants and toddlers for primary and booster immunization [J] . Li Guifan, Zhang Huajie, Zhou Weizhong, Vaccine . 2010,第25期

机译：白喉，破伤风，无细胞百日咳和流感嗜血杆菌b型联合疫苗的安全性和免疫原性，与在中国婴幼儿中分别进行初次和加强免疫的许可等效疫苗相比
3. Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States [J] . Klein Nicola P., Abu-Elyazeed Remon, Cheuvart Brigitte, Human vaccines & immunotherapeutics. . 2019,第4期

机译：用六价性白喉，破伤风，无细胞植物，乙型肝炎，灭活的脊髓灰质炎病毒和嗜血杆菌型B疫苗，免疫原性和安全性
4. Wastage of Diphtheria, Tetanus, Pertussis and Haemophilus influenzae type-b vaccine (Tetravalent vaccine) and its impact on the increase of dose costs [C] . Novaes M. L. O., Almeida R. M. V., Bastos R. R., Pan American Health Care Exchanges Conference . 2011

机译：白喉，破伤风，百日咳和流感嗜血杆菌b型疫苗（四价疫苗）的浪费及其对剂量费用增加的影响
5. Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria tetanus acellular pertussis hepatitis B inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States [O] . Nicola P. Klein, Remon Abu-Elyazeed, Brigitte Cheuvart, 2019

机译：六价白喉破伤风无细胞百日咳乙型肝炎灭活的脊髓灰质炎病毒和乙型流感嗜血杆菌疫苗初次和加强免疫后的免疫原性和安全性：在美国的一项随机试验
6. Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa [O] . Vesikari, Timo, Rivera, Luis, Korhonen, Tiina, 2017

机译：与许可的Infanrix hexa疫苗相比，在六价DTPa-HBV-IPV / Hib混合疫苗中使用2种研究性白喉，破伤风和流感嗜血杆菌b型抗原的初次和加强疫苗接种的免疫原性和安全性

Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa

著录项

相似文献

相关主题

期刊订阅